Leaderboards/Cardiac pacing and defibrillation studies

Cardiac pacing and defibrillation studies

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Margaret Infeld
University of Vermont
2
David M. Zhang
NonInvasive Technologies (United States)
3
Todd L. Teigeler
Winchester Medical Center
4
Gianfranco Mitacchione
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
5
Maarten Z H Kolk
Amsterdam Neuroscience
6
Luuk I.B. Heckman
Maastricht University
7
Karel Breeman
University of Amsterdam
8
Alwin Zweerink
Amsterdam University Medical Centers
9
Paola Pastena
Columbia University Irving Medical Center
10
Karli Gillette
University of Utah

Rising Stars Papers

1
Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias
Scientific Reports|2024
41 cit.
2
Biatrial Resynchronization With Electrogram-Guided Bachmann Bundle Pacing
JACC. Clinical electrophysiology|2024
9 cit.
3
Leadless pacemakers in patients with different stages of chronic kidney disease: Real-world data from the updated i-LEAPER registry
Heart Rhythm|2024
9 cit.
4
Accelerated physiologic pacing in patients with heart failure with preserved ejection fraction: An argument in support of therapeutic heart rate modulation
Heart Rhythm O2|2024
4 cit.
5
Deep behavioural representation learning reveals risk profiles for malignant ventricular arrhythmias
npj Digital Medicine|2024
4 cit.
6
Artificial intelligence–enhanced wearable technology enables ventricular arrhythmia prediction
European Heart Journal - Digital Health|2024
3 cit.
7
A computational study on the influence of antegrade accessory pathway location on the 12-lead electrocardiogram in Wolff–Parkinson–White syndrome
EP Europace|2024
2 cit.
8
New‐Onset Device‐Detected Atrial Fibrillation in Patients With Atrial Floating Dipole Implantable Cardioverter‐Defibrillators: A Propensity Score‐Matched Comparison With Conventional Dual‐Chamber Systems
Journal of Cardiovascular Electrophysiology|2025
2 cit.
9
Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction
JAMA Cardiology|2025
2 cit.
10
Outcomes of leadless pacemaker in chronic kidney disease patients: real-world data from the i-LEAPER registry
EP Europace|2024
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Anne Kathrine Skibelund
World Economic Forum
2
Alexandros Protonotarios
The Task Force for Global Health
3
Quentin R. Youmans
Northwestern University
4
Victor Aboyans
Institut d’Epidémiologie Neurologique et de Neurologie Tropicale
5
Narain Moorjani
Nuffield Orthopaedic Centre
6
Karen G. Zimmerman
West Virginia University
7
Tian Qiu
Aston University
8
Jens Jakob Thune
Amager Hospital
9
Brenda Moura
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
10
Ruogu Li
Shanghai Jiao Tong University

Emerging Leaders Papers

1
2025 ESC/EACTS Guidelines for the management of valvular heart disease
European Heart Journal|2025
625 cit.
2
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Revista Española de Cardiología (English Edition)|2022
297 cit.
3
2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction
Journal of the American College of Cardiology|2024
256 cit.
4
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Revista Española de Cardiología|2022
123 cit.
5
Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator
European Heart Journal|2022
102 cit.
6
Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation
Journal of the American College of Cardiology|2022
79 cit.
7
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the European Society of Cardiology
European Journal of Heart Failure|2023
38 cit.
8
Timing of cardiac resynchronization therapy implantation
EP Europace|2023
29 cit.
9
Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial
Circulation|2024
28 cit.
10
Improved prognosis after cardiac resynchronization therapy over a decade
EP Europace|2023
20 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Jeroen J. Bax
Leiden University
2
John C. Messenger
University of Colorado Anschutz Medical Campus
3
Wojciech Zaręba
University of Rochester Medical Center
4
Luigi Tavazzi
Maria Cecilia Hospital
5
Bruce L. Wilkoff
Cleveland Clinic
6
Piotr Ponikowski
Wroclaw Medical University
7
James E. Ip
Cornell University
8
Adriaan A. Voors
University Medical Center Groningen
9
Arthur M. Feldman
Johns Hopkins University
10
James D. Thomas
University College London

Current Senior Leaders Papers

1
2013 ACCF/AHA Guideline for the Management of Heart Failure
Journal of the American College of Cardiology|2013
12.6k cit.
2
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
European Heart Journal|2012
6.9k cit.
3
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
New England Journal of Medicine|2005
6.5k cit.
4
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
New England Journal of Medicine|2005
6.3k cit.
5
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
European Journal of Heart Failure|2016
5.9k cit.
6
Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure
New England Journal of Medicine|2004
5.8k cit.
7
Cardiac Resynchronization in Chronic Heart Failure
New England Journal of Medicine|2002
4.6k cit.
8
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Journal of the American College of Cardiology|2014
3.5k cit.
9
2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
Circulation|2013
3.3k cit.
10
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
New England Journal of Medicine|2009
3.1k cit.

Reagents for Cardiac pacing and defibrillation studies

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 63

FastScan™ Phospho-Vimentin (Ser56) ELISA Kit

#38107$67,830,490
View Evidence →
Cell Signaling TechnologyEvidence 67

Phospho-PLCbeta3 (Ser537) Antibody

#2481$362
View Evidence →
Cell Signaling TechnologyEvidence 60

TFE3 (F3X8T) Rabbit Monoclonal Antibody

#19950$161,376
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 60

SELENBP1 (F7V8F) Rabbit Monoclonal Antibody

#99613$161,376
View Evidence →
Cell Signaling TechnologyEvidence 67

beta-Tubulin (9F3) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#3623$465
View Evidence →
Cell Signaling TechnologyEvidence 65

Tec (F2K5K) Rabbit Monoclonal Antibody

#99987$161,376
View Evidence →